• Citer

The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.

par Jacquet, S;Malaval, C;Martinez, Laurent O;Sak, Katrin ;Rolland, C;Perez, C;Nauze, M;Champagne, E;Tercé, F;Gachet, Christian;Perret, B;Collet, X;Boeynaems, Jean-Marie ;Barbaras, R
Référence Cellular and molecular life sciences, 62, 21, page (2508-2515)
Publication Publié, 2005-11

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Cell surface receptors for high-density lipoprotein (HDL) on hepatocytes are major partners in the regulation of cholesterol homeostasis. We recently identified a cell surface ATP synthase as a high-affinity receptor for HDL apolipoprotein A-I (apoA-I) on human hepatocytes. Stimulation of this ectopic ATP synthase by apoA-I triggered a low-affinity-receptor-dependent HDL endocytosis by a mechanism strictly related to the generation of ADP. This suggests that nucleotide G-protein-coupled receptors of the P2Y family are molecular components in this pathway. Only P2Y1 and P2Y13 are present on the membrane of hepatocytes. Using both a pharmacological approach and small interference RNA, we identified P2Y13 as the main partner in hepatic HDL endocytosis, in cultured cells as well as in situ in perfused mouse livers. We also found a new important action of the antithrombotic agent AR-C69931MX as a strong activator of P2Y13-mediated HDL endocytosis.